CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zhejiang Taimei Medical Technoogy Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zhejiang Taimei Medical Technoogy Co Ltd
Phone: +86 57382682386p:+86 57382682386 Jiaxing, ZHJ  China Ticker: 25762576

Business Summary
Zhejiang Taimei Medical Technology Co Ltd is a China-based company mainly engaged in the provision of digital solutions for the research and development and commercialisation of pharmaceutical and medical device. The Company mainly designs and provides industry-specific software and digital services to a variety of stakeholders in the pharmaceutical and medical device industry. The Company's cloud-based software mainly provides software as a service (SaaS) products and customized products as well as related technical support, including TrialOS, a digital collaboration platform for the research and development of pharmaceutical and medical device, and PharmaOS, a digital collaboration platform for pharmaceutical and medical device commercialization. The Company's digital services mainly include digital clinical research services and independent reading center (IRC) services. The Company principally conducts its businesses in domestic and overseas markets.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/202412/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman, General Manager ZhaoLu 46 12/1/2016 12/1/2016
Chief Financial Officer ChengwenJiang 42 9/4/2023 9/4/2023
Chief Technology Officer, Executive Director YimingLu 43 3/27/2024 3/27/2024
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 783 (As of 3/31/2024)
Outstanding Shares: 560,416,600 (As of 3/31/2024)
Stock Exchange: HKG


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, November 18, 2024